PCA drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| PCA | associated_with | European ancestry | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome. (2023)
- Unsupervised discovery of ancestry-informative markers and genetic admixture proportions in biobank-scale datasets. (2023)
- Polygenic prediction across populations is influenced by ancestry, genetic architecture, and methodology. (2023)
- Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated. (2022)
- Dimensionality reduction by UMAP to visualize physical and genetic interactions. (2020)
- Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. (2019)
- Eigenanalysis of SNP data with an identity by descent interpretation. (2016)
- Detecting Genomic Signatures of Natural Selection with Principal Component Analysis: Application to the 1000 Genomes Data. (2016)
- Discovering genetic ancestry using spectral graph theory. (2010)
- Population structure and eigenanalysis. (2006)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| pca | drug | 10 | 16 |